<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01516671</url>
  </required_header>
  <id_info>
    <org_study_id>LMU-XX2011</org_study_id>
    <nct_id>NCT01516671</nct_id>
  </id_info>
  <brief_title>Neuroinflammation and Bispectral Index After Subarachnoid Hemorrhage</brief_title>
  <official_title>Pilot Study on the Role of Neuroinflammation in the Pathophysiology of Subarachnoid Hemorrhage and the Value of the Bilateral Bispectral Index for Early Diagnosis of Cerebral Ischemia After Subarachnoid Hemorrhage.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ludwig-Maximilians - University of Munich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Subarachnoid hemorrhage (SAH) is associated with a high mortality and frequently leads to
      severe disability in survivors caused by cerebral vasospasm and infarction.

      This study aims to elucidate the role of neuroinflammation (endocannabinoids and cortisol
      levels in cerebrospinal fluid) in the pathophysiology of cerebral vasospasm and the value of
      the bilateral bispectral index (BIS) for the early diagnosis of cerebral vasospasm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subarachnoid hemorrhage (SAH) or bleeding in the brain is a form of stroke. SAH mostly
      results from ruptured aneurysms. This severe disease often results in death or severe
      physical or cognitive disabilities and reduced quality of life. One frequent complication
      after SAH is cerebral vasospasm, a spasm of the big arteries accompanied by infarction of
      healthy brain tissue. The pathophysiologic processes which drive vasospasm remain unclear.
      This study aims to examine the role of endocannabinoids and cortisol in cerebrospinal fluid
      during the development of cerebral vasospasm. Additionally, this study examines whether side
      difference in the processed electroencephalogram (bilateral bispectral index) may be useful
      for early detection of cerebral vasospasm.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Concentrations of endocannabinoids and corticoids in cerebrospinal fluid and blood.</measure>
    <time_frame>Once per day from day 1 until day 14 after hospital admission</time_frame>
    <description>Samples of cerebrospinal fluid and blood will be collected every day at 8am on hospital day 1-14 and the concentrations of the following substances will be determined:
Anandamide
2-arachidonoylglycerol
2-arachidonoylglycerol-ether
N-arachidonoyldopamine
N-arachidonylglycine
O-arachidonylethanolamide
Palmitoylethanolamide
Cortisol
Corticotropin-releasing hormone (in CSF only)
Corticosteroid-binding globulin (in blood only)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bilateral Bispectral Index</measure>
    <time_frame>Every second from 0:01 am until 23:59 pm on hospital day 1,2,3,4,5,6,7,8,9,10,11,12,13,14</time_frame>
    <description>The Bispectral Index is calculated every second by the BIS Vista monitor. These data will be recorded continuously from 0:01 am until 23:59 pm.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transcranial Doppler</measure>
    <time_frame>Every day at 8 am from day 1 until day 14 after hospital admission</time_frame>
    <description>The mean velocities in middle cerebral and anterior cerebral arteries will be determined by transcranial Doppler</description>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Subarachnoid Hemorrhage</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cerebrospinal fluid Blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients after acute SAH admitted to neurosurgical ICU
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admission to neurosurgical ICU Klinikum der Universität München

          -  SAH

          -  External CSF drainage

        Exclusion Criteria:

        - AGE &lt; 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Volker Huge, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum der Universität München, Ludwig-Maximilians-University, Department of Anaesthesiology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cyrill Hornuss, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum der Universität München, Ludwig-Maximilians-University, Department of Anaesthesiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum der Universität München</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Altay T, Smithason S, Volokh N, Rasmussen PA, Ransohoff RM, Provencio JJ. A novel method for subarachnoid hemorrhage to induce vasospasm in mice. J Neurosci Methods. 2009 Oct 15;183(2):136-40. doi: 10.1016/j.jneumeth.2009.06.027. Epub 2009 Jul 1.</citation>
    <PMID>19576247</PMID>
  </reference>
  <reference>
    <citation>Huge V, Lauchart M, Magerl W, Beyer A, Moehnle P, Kaufhold W, Schelling G, Azad SC. Complex interaction of sensory and motor signs and symptoms in chronic CRPS. PLoS One. 2011 Apr 29;6(4):e18775. doi: 10.1371/journal.pone.0018775.</citation>
    <PMID>21559525</PMID>
  </reference>
  <reference>
    <citation>Huge V, Lauchart M, Förderreuther S, Kaufhold W, Valet M, Azad SC, Beyer A, Magerl W. Interaction of hyperalgesia and sensory loss in complex regional pain syndrome type I (CRPS I). PLoS One. 2008 Jul 23;3(7):e2742. doi: 10.1371/journal.pone.0002742.</citation>
    <PMID>18648647</PMID>
  </reference>
  <reference>
    <citation>Provencio JJ, Altay T, Smithason S, Moore SK, Ransohoff RM. Depletion of Ly6G/C(+) cells ameliorates delayed cerebral vasospasm in subarachnoid hemorrhage. J Neuroimmunol. 2011 Mar;232(1-2):94-100. doi: 10.1016/j.jneuroim.2010.10.016. Epub 2010 Nov 6.</citation>
    <PMID>21059474</PMID>
  </reference>
  <reference>
    <citation>Lin CL, Dumont AS, Calisaneller T, Kwan AL, Hwong SL, Lee KS. Monoclonal antibody against E selectin attenuates subarachnoid hemorrhage-induced cerebral vasospasm. Surg Neurol. 2005 Sep;64(3):201-5; discussion 205-6.</citation>
    <PMID>16099244</PMID>
  </reference>
  <reference>
    <citation>Wolf SA, Tauber S, Ullrich O. CNS immune surveillance and neuroinflammation: endocannabinoids keep control. Curr Pharm Des. 2008;14(23):2266-78. Review.</citation>
    <PMID>18781977</PMID>
  </reference>
  <reference>
    <citation>Tischner D, Reichardt HM. Glucocorticoids in the control of neuroinflammation. Mol Cell Endocrinol. 2007 Sep 15;275(1-2):62-70. Epub 2007 May 4. Review.</citation>
    <PMID>17555867</PMID>
  </reference>
  <reference>
    <citation>Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R, Keh D, Kupfer Y, Oppert M, Meduri GU. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA. 2009 Jun 10;301(22):2362-75. doi: 10.1001/jama.2009.815. Review.</citation>
    <PMID>19509383</PMID>
  </reference>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2012</study_first_submitted>
  <study_first_submitted_qc>January 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2012</study_first_posted>
  <last_update_submitted>November 11, 2013</last_update_submitted>
  <last_update_submitted_qc>November 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 13, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ludwig-Maximilians - University of Munich</investigator_affiliation>
    <investigator_full_name>Cyrill Hornuss</investigator_full_name>
    <investigator_title>Study Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Subarachnoid hemorrhage</keyword>
  <keyword>Cerebral vasospasm</keyword>
  <keyword>Neuroinflammation</keyword>
  <keyword>Bilateral Bispectral Index</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

